![Mona Ashiya](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mona Ashiya
Direktor/Vorstandsmitglied bei
SHATTUCK LABS, INC.
Vermögen: - $ am 31.08.2026
Profil
Mona Ashiya is currently Director at Disc Medicine Opco, Inc. since 2021, Independent Director at Shattuck Labs, Inc. starting in 2025, Independent Director at Yarrow Bioscience, Inc. starting in 2025, and General Partner at OrbiMed Advisors Private Equity since 2010.
Former roles include Independent Director at Sierra Oncology, Inc. from 2019 to 2022, Director at Prevail Therapeutics, Inc., Director at Gemini Therapeutics, Inc., Independent Director at Disc Medicine, Inc. from 2021 to 2025, Associate Analyst at JPMorgan Securities LLC from 2009 to 2010, and Research Analyst at Needham & Co. LLC.
Education includes a doctorate from the University of Pittsburgh and an undergraduate degree from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DISC MEDICINE, INC. -.--% | 11.06.2025 | 0 ( -.--% ) | - $ | 31.08.2026 |
Aktive Positionen von Mona Ashiya
| Unternehmen | Position | Beginn |
|---|---|---|
| SHATTUCK LABS, INC. | Direktor/Vorstandsmitglied | 25.08.2025 |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Private Equity Investor | 01.01.2010 |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Direktor/Vorstandsmitglied | 01.09.2021 |
Ehemalige bekannte Positionen von Mona Ashiya
| Unternehmen | Position | Ende |
|---|---|---|
| DISC MEDICINE, INC. | Direktor/Vorstandsmitglied | 03.10.2025 |
| SIERRA ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 01.07.2022 |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Private-Equity-Analyst | 30.11.2010 |
Needham & Co. LLC
 Needham & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31.12.2006 |
| PREVAIL THERAPEUTICS INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Mona Ashiya
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
86
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Needham & Co. LLC
Needham & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Shattuck Labs, Inc.
 Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Commercial Services |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
Disc Medicine, Inc.
 Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
